{"version":"1.0","provider_name":"Brakke\u54a8\u8be2\u7f51\u7ad9","provider_url":"https:\/\/brakkeconsulting.com\/zh","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"onq6Rm4PDv\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/14068\/\">2006\u5e742\u670810\u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u7b80\u62a5<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/zh\/14068\/embed\/#?secret=onq6Rm4PDv\" width=\"600\" height=\"338\" title=\"\u300a Animal Health News &#038; Notes for February 10, 2006 \u300b\u2014Brakke Consulting Website\" data-secret=\"onq6Rm4PDv\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"printer friendly version ******************************************************************* Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 10, 2006 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM, MBA ******************************************************************* IN THE NEWS: &nbsp; earnings news Bioniche Gold Kist ImmuCell Intervet Premium Standard Farms &nbsp; &nbsp; other news Bayer Intervet Land O&rsquo;Lakes Moark PetArk PetSmart Pfizer Renessen &nbsp; ******************************************************************* COMPANY EARNINGS RELEASES &nbsp; &gt;&nbsp; Akzo Nobel reported financial results for the year 2005.&nbsp; Intervet produced strong results in 2005 with revenues increasing by 7% to EUR 1,094 million ($1,295 million). The business&rsquo; performance was boosted by efficiency improvements in manufacturing, supply chain, and marketing, resulting in an EBIT of EUR 238 million ($282 million), up 29% from 2004.&nbsp; For the quarter, Intervet reported revenues of EUR 278 million ($329 million), an increase of 6% compared to the fourth quarter of 2004. (company website)&nbsp; &nbsp; &gt; Bioniche Life Sciences Inc. released results for its second quarter of fiscal 2006 ended December 31, 2005.&nbsp; Animal Health sales for the quarter were C$6.1 million (US$5.2 million), an increase of 9% compared to the same quarter in the prior year.&nbsp; The increase reflected increased sales of Folltropin-V across all market jurisdictions. (company website) &nbsp; &gt; ImmuCell Corporation announced the results of its operations for the three and twelve month periods ended December 31, 2005.&nbsp; For the threeView Full Post;"}